DF20JZZ
Stereotactic Radiosurgery Liver to None with None, Stereotactic Gamma Beam Radiosurgery Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | D Radiation Therapy |
| Body System | F Hepatobiliary System and Pancreas |
| Operation | 2 Stereotactic Radiosurgery |
| Body Part | 0 Liver |
| Approach | J Stereotactic Gamma Beam Radiosurgery |
| Device | Z None |
| Qualifier | Z None |
Procedure Overview
Stereotactic radiosurgery to the liver, gallbladder, bile ducts, or pancreas delivers a small number of very high-dose radiation beams that converge precisely on a tumor, sparing the surrounding tissue far more than conventional radiation. It is most often used for liver tumors, including hepatocellular carcinoma and metastases from colorectal or other cancers, in patients who are not surgical candidates because of tumor location, liver function, or overall health. Pancreatic tumors are treated this way less frequently, usually when surgery is not feasible or as an adjunct to chemotherapy.
The treatment is planned around the organ's constant motion from breathing, so imaging and positioning systems track the target between and during sessions. A course typically involves one to five treatments rather than the many weeks required for standard radiation, which shortens recovery time and reduces the burden on patients who are often already managing significant illness.
Because the liver and pancreas sit near the stomach, intestines, and kidneys, planning teams work to limit dose to those structures, and patients may need markers or breath-hold techniques placed beforehand to keep the target steady.
Anatomy & Axis Detail
Liver
The liver's large size and predictable respiratory motion make it a frequent target for stereotactic radiosurgery, a technique that delivers a small number of very high, precisely focused external beam doses to a tumor such as hepatocellular carcinoma or a limited number of metastases. Because the liver moves substantially with breathing, treatment planning typically incorporates respiratory tracking, fiducial markers, or gating to ensure the beams converge accurately on the lesion despite this motion, sparing as much normal hepatic tissue as possible. This approach is often chosen for patients whose overall liver function or tumor location makes resection or standard fractionated radiation less suitable, since the ablative dose concentrated in one area can achieve tumor control with a shorter treatment course.
Modality Qualifier: Stereotactic Gamma Beam Radiosurgery
Stereotactic Gamma Beam Radiosurgery specifically denotes treatment delivered by a dedicated multisource cobalt-60 gamma unit, most recognizably the Gamma Knife, which focuses many individual gamma beams onto a small intracranial target with sub-millimeter precision. It is a narrower category than Stereotactic Other Photon Radiosurgery, which encompasses linear-accelerator-based systems instead of a fixed cobalt source array.
Coding & Documentation
Coders should confirm the documentation explicitly names stereotactic technique (SBRT/SRS, CyberKnife, Gamma Knife-style dose delivery) rather than assuming it from a high-dose regimen described only as "radiation." The operative or treatment note must identify the specific hepatobiliary or pancreatic structure targeted, since the body part value depends on it. A frequent error is coding the number of treatment sessions or fractions as if it changes the root operation; stereotactic radiosurgery is coded the same regardless of how many sessions the course is split into, as long as the technique meets the stereotactic definition. Another common mistake is defaulting to "Other Radiation" when the note actually describes a stereotactic delivery system, or vice versa, coding stereotactic when the therapy was standard fractionated beam radiation. Physician documentation of the qualifier (isodose, if applicable) should also be checked against the radiation oncology report rather than inferred.